FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080578 [Registered on: 14/02/2025] Trial Registered Prospectively
Last Modified On: 11/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A Clinical trial to study effect of Asitakadi Churn in patients of Katigrah 
Scientific Title of Study   A Randomized controlled clinical trial to study the efficacy of Asitakadi Churn in the management of Katigrah with special reference to Lumbar Spondylosis  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Akshara Vikas Suryawanshi  
Designation  PG Scholar  
Affiliation  Siddhakala Ayurveda Mahavidyalaya Sangamner  
Address  OPD number 1 Kayachikitsa department Siddhakala Ayurveda Mahavidyalaya Pimparne road Sangamner Ahmadnagar Maharashtra 422605 India

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  7972534800  
Fax    
Email  aksharasuryawanshi1698@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vd Omkar Kortikar 
Designation  Head of department of Kayachikitsa  
Affiliation  Siddhakala Ayurveda Mahavidyalaya Sangamner  
Address  Kayachikitsa department Siddhakala Ayurveda Mahavidyalaya Pimparne road Sangamner Ahmadnagar Maharashtra 422605

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9850218004  
Fax    
Email  omkar_kortikar@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Vd Omkar Kortikar 
Designation  Head of department of Kayachikitsa  
Affiliation  Siddhakala Ayurveda Mahavidyalaya Sangamner  
Address  Kayachikitsa department Siddhakala Ayurveda Mahavidyalaya Pimparne road Sangamner Ahmadnagar Maharashtra 422605

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9850218004  
Fax    
Email  omkar_kortikar@yahoo.com  
 
Source of Monetary or Material Support  
Siddhakala Ayurveda Mahavidyalaya Pimparne road Sangamner 422605 Maharashtra India  
 
Primary Sponsor  
Name  Akshara Vikas Suryawanshi  
Address  Siddhakala Ayurveda Mahavidyalaya Sangamner Maharashtra 422605 
Type of Sponsor  Other [Own] 
 
Details of Secondary Sponsor  
Name  Address 
Nil   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Akshara Vikas Suryawanshi   Siddhakala Ayurveda Mahavidyalaya Sangamner Pimparne road Maharashtra India 422605  Ground floor OPD number 1 Kayachikitsa department
Ahmadnagar
MAHARASHTRA 
7972534800

aksharasuryawanshi1698@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Board of Ayurved research and statistics committee of Siddhakala Ayurveda Mahavidyalaya Sangamner   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M858||Other specified disorders of bonedensity and structure. Ayurveda Condition: VATAVYADHIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Asitakadi Churn , Reference: Bhavprakash madhyamkhand Aamvaat , Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 28 Days, anupAna/sahapAna: Yes(details: Ushnodak ), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Abhadi Churn , Reference: Yogratnakar Vatvyadhichikitsa , Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 28 Days, anupAna/sahapAna: Yes(details: Ushnodak ), Additional Information: -
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients having signs and symptoms of Katigrah mentioned in the classic
Radiological degenerative changes in lumbar Spine
The Roland-Morris low back pain and disability questionnaire score more than or equal to 5
Patients of both sexes between 30-60 years of age 
 
ExclusionCriteria 
Details  Patients age less than 30 years and more than 60 years
Patients having complicated diseases like fracture and of vertebrae spinal tumor malignancy and tuberculosis of spine
Patient with history of trauma to the spine and with marked deformities of spinal cord and disc prolapse
Known case of Ankylosing spondylosis Rheumatoid arthritis gouty Arthritis
Pregnant and lactating women  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the effect of Asitakadi Churn particularly on the Roland and Morris low back pain and Disability questionnaire visual Analogue scale and clinical features of Katigrah with special reference to lumbar spondylosis
To compare the effect of Asitakadi Churn and Abhadi Churn  
28 days  
 
Secondary Outcome  
Outcome  TimePoints 
To review and study the literature of Katigrah
To review and study the literature of lumbar spondylosis
Any new theoretical and practical concept if found will be noted down  
28 days  
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   28/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This Study is Randomized open labelled Active Controlled trial  70 patients taken for study 35 patients in each group 
Comparing safety and efficacy of Asitakadi Churn with Ushnodak  And Abhadi Churn with Ushnodak for 28 days in 70 patients of Katigrah 
 
Close